<DOC>
	<DOCNO>NCT00605371</DOCNO>
	<brief_summary>This study intend demonstrate bioequivalence lack food effect 250mg lamotrigine XR healthy male female volunteer</brief_summary>
	<brief_title>Bioequivalence Food Effect 250mg Lamotrigine XR</brief_title>
	<detailed_description />
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Male female subject age 19 55 year , inclusive . Body weight &gt; 50 kg ( male ) &gt; 45 kg ( female ) BMI within range 19 32 kg/m2 inclusive . Healthy determine responsible physician , base medical evaluation include history , physical examination , laboratory test , vital sign ECG . A subject clinical abnormality laboratory parameter outside reference range population study may include Investigator considers find introduce additional risk factor interfere study procedure Female subject nonchild bear potential eligible participate meet follow criterion : Postmenopausal female define amenorrhoeic great 2 year appropriate clinical profile , e.g . age appropriate , history vasomotor symptom . However indicate confirmed oestradiol FSH level consistent menopause ( accord local laboratory range ) . Premenopausal female document ( medical report verification ) hysterectomy and/or bilateral oophorectomy , latter reproductive status woman confirm follow hormone level assessment . Female subject child bear potential eligible participate comply contraception requirement . A negative prestudy Hepatitis B surface antigen ( HBsAg ) , Hepatitis C antibody , HIV antibody result screen . A negative prestudy urine drug screen . A negative screen alcohol ( urine , blood breath test ) . Signed date write informed consent prior admission study . Female subject childbearing potential eligible participate unwilling unable use appropriate method contraception outline inclusion criterion least commencement last normal period prior first dose study medication ; continue first normal period ( define normal woman , term duration quantity menses ) treatment 5 half life study medication , whichever long . Female subject pregnant ( positive serum human chorionic gonadotrophin ( hCG ) test screen ) lactating . Female subject use hormonal contraceptive precaution include progesteronecoated IUD . Female subject use oestrogencontaining hormone replacement therapy . Subjects receive lamotrigine previously ( subject receive placebo previous study allow ) History evidence drug alcohol abuse within 12 month study start . QTc &gt; 450msec woman QTc &gt; 430 msec men screen 12lead ECG . Current smokers 10 cigarette per day . History regular alcohol consumption average &gt; 7 drinks/week woman &gt; 14 drinks/week men within 6 month screen . One drink equivalent 12 g alcohol = 5 ounce ( 150 ml ) wine 12 ounce ( 360 ml ) beer 1.5 ounce ( 45 ml ) 80 proof distil spirit . Has receive prescribe nonprescribed medication ( include vitamin herbal remedy ) within 14 day prior dose day , opinion Principal/CoInvestigator , may interfere study procedure compromise safety . History gastrointestinal , hepatic , renal disease condition know interfere absorption , distribution , metabolism excretion drug . History clinically relevant skin rash , opinion investigator , might interfere conduct study . Treatment investigational drug within 30 day 5 halflives ( whichever longer ) precede first dose study medication . History allergic , anaphylactic , hypersensitivity idiosyncratic reaction ( ) lamotrigine drug similar type .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Food Effects</keyword>
</DOC>